Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04076943 · ClinicalTrials.gov registry record · Phase 2
Evaluation of Efficacy and Safety of Roxadustat for the Treatment of Chemotherapy Induced Anemia
A Phase 2 study, sponsored by Kyntra Bio.
- Completed
- Registry status
- Phase 2
- Development phase
- 92
- Enrollment target
NCT04076943 is a Phase 2 study that has completed, run by Kyntra Bio. The registered enrollment target is 92 participants.
The verdict
NCT04076943, a Phase 2 study, has completed, sponsored by Kyntra Bio.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 92 participants
- Enrollment target
Study Summary
The purpose of this study is to find out if roxadustat (also known as FG-4592) is safe and effective for the treatment of anemia in participants receiving chemotherapy treatment for cancer.
Interventions
- DRUG Roxadustat
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2019-08-20 |
| Est. Completion | 2021-04-23 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04076943
The ClinicalTrials.gov registry entry for NCT04076943 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kyntra Bio, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Roxadustat is the first listed.
NCT04076943 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04076943 about?
NCT04076943 is a clinical study titled "Evaluation of Efficacy and Safety of Roxadustat for the Treatment of Chemotherapy Induced Anemia". The purpose of this study is to find out if roxadustat (also known as FG-4592) is safe and effective for the treatment of anemia in participants receiving chemotherapy treatment for cancer.
What is the current status of trial NCT04076943?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 92 participants. The study started on 2019-08-20. Estimated completion is 2021-04-23.
What interventions are being tested in trial NCT04076943?
The interventions under investigation include: Roxadustat (DRUG).
Who is sponsoring clinical trial NCT04076943?
This trial is sponsored by Kyntra Bio, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.